diacerein has been researched along with methotrexate in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Nikitin, AV; Starodubtseva, IA; Vasilieva, LV | 2 |
| Collaud Basset, S; Louthrenoo, W; Nanagara, R; Nilganuwong, S; Siripaitoon, B | 1 |
1 trial(s) available for diacerein and methotrexate
| Article | Year |
|---|---|
Diacerein for the treatment of rheumatoid arthritis in patients with inadequate response to methotrexate: a pilot randomized, double-blind, placebo-controlled add-on trial.
Topics: Adult; Anthraquinones; Antirheumatic Agents; Arthritis, Rheumatoid; Double-Blind Method; Female; Humans; Male; Methotrexate; Middle Aged; Pilot Projects; Retreatment; Treatment Outcome | 2019 |
3 other study(ies) available for diacerein and methotrexate
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Correction of an inflammatory process with an interleukin-1 inhibitor in the combination treatment of secondary osteoarthritis in the presence of comorbid condition].
Topics: Adult; Aged; Anthraquinones; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Cartilage Oligomeric Matrix Protein; Combined Modality Therapy; Comorbidity; Female; Humans; Interleukin-1; Low-Level Light Therapy; Male; Methotrexate; Middle Aged; Osteoarthritis; Outcome Assessment, Health Care; Severity of Illness Index | 2015 |
[The Analysis of Efficacy of The Application of Interleukin-1 Inhibitor in the Complex Therapy of Secondary Osteoarthritis Taking Into Account the Dynamics of Clinical and Functional Indicators].
Topics: Adult; Anthraquinones; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Combined Modality Therapy; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Interleukin-1; Laser Therapy; Male; Methotrexate; Middle Aged; Osteoarthritis, Knee; Patient Acuity; Quality of Life; Recovery of Function; Treatment Outcome | 2016 |